4//SEC Filing
Burhop Kenneth 4
Accession 0001209191-19-011192
CIK 0000917520other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 5:11 PM ET
Size
11.5 KB
Accession
0001209191-19-011192
Insider Transaction Report
Form 4
Burhop Kenneth
CORPVP,CHIEFSCIENTIFIC OFFICER
Transactions
- Award
Common Stock
2019-02-14+604→ 13,058 total - Award
Common Stock
2019-02-14+1,263→ 12,454 total - Award
Common Stock
2019-02-14+1,332→ 11,191 total
Footnotes (3)
- [F1]On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 14, 2016 Performance Stock Award. Accordingly, 34% of the shares will vest on March 14, 2019 at 150% of target, the third anniversary of the grant date.
- [F2]On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018, at least 3% and up to a maximum of 11% increase in annual revenue over the prior fiscal year, under the March 13, 2017 Performance Stock Award. Accordingly, 33% of the shares will vest on March 13, 2019 at 150% of target, the second anniversary of the grant date.
- [F3]On February 14, 2019, the Compensation Committee certified that the Company achieved its performance goal for fiscal year 2018 under the March 13, 2018 performance stock award at or above the threshold level based on annual organic revenue growth over the prior fiscal year. Accordingly, 33% of the shares will vest on March 13, 2019 at 89.5% of target, the first anniversary of the grant date.
Issuer
INTEGRA LIFESCIENCES HOLDINGS CORP
CIK 0000917520
Entity typeother
Related Parties
1- filerCIK 0001601582
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 5:11 PM ET
- Size
- 11.5 KB